AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Prevention of Mental Disorders Through Self-efficacy Interventions

RecruitingNAAges 18 Years - 30 YearsAllHealth and Medical University Potsdam
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Low self-efficacy is a transdiagnostic risk factor for several mental disorders. Self-efficacy refers to one's belief that one is capable of performing a behavior necessary to successfully complete a task or achieve a goal. Consistent with theoretical models and empirical findings, individuals with low self-efficacy are more likely to perceive challenges as uncontrollable and threatening and thus are at increased risk for developing mental disorders during sensitive periods such as young adulthood. Self-efficacy interventions have been shown to be effective in promoting health behavior change, quality of life, and treatment adherence in patients with serious illnesses, as well as motivation and performance in students and employees. However, whether targeted self-efficacy training can prospectively prevent the onset of full-threshold anxiety, affective, and substance use disorders in you

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. age 18-30 years and 2. low scores (โ‰ค24) on the German version of the General Self-Efficacy Scale (i.e., more than one standard deviation (5.4) below the mean score of 29.4 in the German norm sample; The cutoff will be raised to scores below the mean of 29.4 (โ‰ค30) if not enough participants with low self-efficacy scores of โ‰ค24 and without 12-month mental disorders are found and this leads to serious problems regarding the recruitment phase and the timeline of the project. 3. ability to participate in the course (German language proficiency, availability during the intervention period) Exclusion Criteria: 1. 12-month anxiety, affective, or substance use disorder (excluding nicotine dependence) 2. current psychological/psychopharmacological intervention or treatment seeking for psychological problems 3. acute suicidality; Individuals who report acute suicidality will be withdrawn from the study and referred to treatment.
๐Ÿ’Š

What it tests

  • Cognitive-Behavioral Intervention to increase Self Efficacy
  • Placebo: Weekly Recap and Group Discussion on Psychological Experiments
๐Ÿ“

Where

1 site
Health and Medical University Potsdam
Potsdam, Germany
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy